Here's Why Aurinia Pharmaceuticals Inc. Gained 32.2% in the First Half of 2018 [The Motley Fool]
Aurinia Pharmaceuticals Inc - Common Shares (AUPH)
Last aurinia pharmaceuticals inc - common shares earnings: 3/5 04:02 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.auriniapharma.com
Company Research
Source: The Motley Fool
An additional indication for the company's lead candidate has been a big source of encouragement. Cory Renauer ( TMFang4apples ) Jul 14, 2018 at 3:47PM What happened Shares of Aurinia Pharmaceuticals Inc. ( NASDAQ:AUPH ) , a clinical-stage biotechnology company, gained 32.2% in the first half of 2018, according to data from S&P Global Market Intelligence . Investors anticipating success with the company's lead candidate, voclosporin, have been pushing up the stock. So what There is an enormous unmet need for effective new lupus treatments, and it looks as if voclosporin could become an important option that generates $1 billion-plus annual sales. During the midstage Aura study, adding voclosporin to standard care produced complete remissions at more than twice the rate of standard care alone. Image source: Getty Images. Aurinia's stoc
Show less
Read more
Impact Snapshot
Event Time:
AUPH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AUPH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AUPH alerts
High impacting Aurinia Pharmaceuticals Inc - Common Shares news events
Weekly update
A roundup of the hottest topics
AUPH
News
- We're Not Worried About Aurinia Pharmaceuticals' (NASDAQ:AUPH) Cash Burn [Yahoo! Finance]Yahoo! Finance
- Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.MarketBeat
- Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase Program [Yahoo! Finance]Yahoo! Finance
- Aurinia Receives Exemptive Relief from Canadian Securities Regulators for Share Repurchase ProgramBusiness Wire
- Aurinia to Participate in Upcoming Investor Healthcare ConferencesBusiness Wire
AUPH
Earnings
- 2/15/24 - Miss
AUPH
Sec Filings
- 3/20/24 - Form SC
- 3/7/24 - Form 4
- 3/7/24 - Form 4
- AUPH's page on the SEC website